![]() | |
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number |
![]() |
PubChem CID | |
ChemSpider |
|
UNII |
![]() |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.047.924 ![]() |
Chemical and physical data | |
Formula | C20H29N5O6 |
Molar mass | 435.481 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Trimazosin is a sympatholytic alpha-1 blocker.[1][2]
| |||||
---|---|---|---|---|---|
Sympatholytics (antagonize α-adrenergic vasoconstriction) |
| ||||
Other antagonists |
| ||||
|
| |||||
---|---|---|---|---|---|
α1 |
| ||||
α2 |
| ||||
β |
| ||||
|
| |
---|---|
Simple piperazines (no additional rings) |
|
Phenylpiperazines |
|
Benzylpiperazines |
|
Diphenylalkylpiperazines (benzhydrylalkylpiperazines) |
|
Pyrimidinylpiperazines |
|
Pyridinylpiperazines |
|
Benzo(iso)thiazolylpiperazines |
|
Tricyclics (piperazine attached via side chain) |
|
Others/Uncategorized |
|
![]() | This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |